Wasabi 6-(methylsulfinyl)hexyl isothiocyanate induces apoptosis in human colorectal cancer cells through p53-independent mitochondrial dysfunction pathway

BioFactors
Satoshi YanoDe-Xing Hou

Abstract

6-(Methylsulfinyl)hexyl isothiocyanate (6-MSITC), a major bioactive compound in Wasabi [Wasabia japonica (Miq.) Matsum.], has revealed the inhibitory effect on colon carcinogenesis in rat cancer model although the underlying mechanism is unclear. In this study, we used two types of human colorectal cancer cells (HCT116 p53+/+ and HCT116 p53-/- ) to investigate the anticancer activity and molecular mechanisms of 6-MSITC. Interestingly, 6-MSITC inhibited the cell proliferation in both types of cells with similar IC50 value although a light increase in the phosphorylation and accumulation of P53 protein was observed in HCT116 p53+/+ cells at 24 h after treatment. In addition, 6-MSITC increased the ratio of proapoptotic cells in both types of cells with the same fashion in a p53-independent manner. The data from mitochondrial analysis revealed that 6-MSITC enhanced the ratio of proapoptotic B-cell lymphoma-2-associated X protein/antiapoptotic myeloid cell leukemia 1, and sequentially caused mitochondrial membrane potential (ΔΨm ) loss, cytochrome c release, and caspase-3 activation in both types of cells. Taken together, Wasabi 6-MSITC induced apoptosis of human colorectal cancer cells in p53-independent mitochondrial dysfunction p...Continue Reading

References

Jul 9, 2002·Apoptosis : an International Journal on Programmed Cell Death·C Soldani, A Ivana Scovassi
Oct 25, 2003·Oncogene·Wafik S El-Deiry
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John BoyerPatrick G Johnston
Jul 13, 2004·International Journal of Food Microbiology·Il Shik ShinKinae Naohide
Nov 19, 2004·Cancer Research·Thomas J O'FarrellDan L Longo
May 6, 2006·Cell Death and Differentiation·C GarridoG Kroemer
May 17, 2007·Apoptosis : an International Journal on Programmed Cell Death·Paloma BragadoAlmudena Porras
May 22, 2007·Molecular Cancer Therapeutics·Anna Herman-AntosiewiczShivendra V Singh
Dec 20, 2007·The Journal of Biological Chemistry·Marc GermainVincent Duronio
Apr 24, 2008·Nature Reviews. Molecular Cell Biology·Todd RileyArnold Levine
Aug 8, 2009·Annual Review of Genetics·Chunxin Wang, Richard J Youle
Dec 23, 2009·Experimental Cell Research·Zafar Mahmood, Yogeshwer Shukla
Feb 19, 2010·Nature·Rameen BeroukhimMatthew Meyerson
Feb 26, 2010·Cold Spring Harbor Perspectives in Biology·Magali OlivierPierre Hainaut
Jul 19, 2011·Developmental Cell·Jean-Claude Martinou, Richard J Youle
Jun 23, 2012·Accounts of Chemical Research·Fernando Torres Andón, Bengt Fadeel
Mar 29, 2014·ELife·David Wallach, Andrew Kovalenko
Dec 9, 2014·Molecular Cell·Thibaud T RenaultJerry E Chipuk
Apr 5, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Julianne D TwomeyBaolin Zhang
Jun 17, 2016·Cell Death & Disease·J ZhangX Luo
Oct 28, 2016·Nature·András KotschyOlivier Geneste
Nov 27, 2016·Oncotarget·Karin HientzThomas Efferth
Sep 3, 2017·European Journal of Nutrition·Paola ArcidiaconoRoberta Spaccapelo

❮ Previous
Next ❯

Citations

Nov 6, 2018·Journal of Cellular Physiology·Saeed SamarghandianTahereh Farkhondeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.